TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo
Authors
Keywords
Pancreatic cancer, Cancer treatment, Gene expression, Small interfering RNAs, Apoptosis, Cell proliferation, Polymerase chain reaction, Transfection
Journal
PLoS One
Volume 10, Issue 12, Pages e0144969
Publisher
Public Library of Science (PLoS)
Online
2015-12-29
DOI
10.1371/journal.pone.0144969
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Novel Anti-TM4SF1 Antibody-Drug Conjugates with Activity against Tumor Cells and Tumor Vasculature
- (2015) A. Visintin et al. MOLECULAR CANCER THERAPEUTICS
- TM4SF1: a new vascular therapeutic target in cancer
- (2014) Chi-Iou Lin et al. ANGIOGENESIS
- Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer
- (2014) Lucas de Sousa Cavalcante et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
- (2013) S Nath et al. Oncogenesis
- Reversal of Multidrug Resistance by Gefitinib Via RAF1/ERK Pathway in Pancreatic Cancer Cell Line
- (2012) Zhi Xiao et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial–mesenchymal transition
- (2011) Mi-Sook Lee et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Combinational therapy: New hope for pancreatic cancer?
- (2011) Si Shi et al. CANCER LETTERS
- JNK signaling activity regulates cell–cell adhesions via TM4SF5-mediated p27Kip1 phosphorylation
- (2011) Hyeonjung Kim et al. CANCER LETTERS
- Classical resistance mechanisms
- (2011) W. Jäger INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration
- (2011) Nathalie Allioli et al. PROSTATE
- TM4SF5 accelerates G1/S phase progression via cytosolic p27Kip1 expression and RhoA activity
- (2010) Hyeonjung Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The L6 Protein TM4SF1 Is Critical for Endothelial Cell Function and Tumor Angiogenesis
- (2009) S.-C. Shih et al. CANCER RESEARCH
- Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
- (2009) T. Arumugam et al. CANCER RESEARCH
- The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: implication for tumour cell motility
- (2008) T. Lekishvili et al. JOURNAL OF CELL SCIENCE
- Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma
- (2008) Sin-Ae Lee et al. JOURNAL OF CLINICAL INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started